期刊论文详细信息
Orphanet Journal of Rare Diseases
X-linked intellectual disability type Nascimento is a clinically distinct, probably underdiagnosed entity
Alma Kuechler4  Dagmar Wieczorek4  Andreas Tzschach3  Angelika Rieß3  Deborah Morrogh2  Alison Male2  Hermann-Josef Lüdecke4  Vanesa López-González1  Udo Koehler5  Diana S Johnson6  Encarna Guillén-Navarro1  Claudia Dufke3  Karin Buiting4  Peter Bauer3  Johanna Christina Czeschik4 
[1] Unidad de Genética Médica, Servicio de Pediatría, Hospital Clínico Universitario Virgen de la Arrixaca, El Palmar, Murcia, Spain;Great Ormond Street Hospital for Children, London, UK;Institut für Medizinische Genetik und Angewandte Genomik, Universitätsklinikum Tübingen, Tübingen, Germany;Institut für Humangenetik, Universitätsklinikum Essen, Universität Duisburg-Essen, Hufelandstr. 55, 45122, Essen, Germany;MGZ - Medizinisch Genetisches Zentrum, München, Germany;Sheffield Children’s Hospital, Sheffield, UK
关键词: Onychodystrophy;    Prominent supraorbital ridges;    Synophrys;    Intellectual disability;    Ubiquitin-conjugating enzyme;    HHR6A;    RAD6A;    UBE2A;   
Others  :  863528
DOI  :  10.1186/1750-1172-8-146
 received in 2013-07-09, accepted in 2013-09-15,  发布年份 2013
PDF
【 摘 要 】

X-linked intellectual disability type Nascimento (MIM #300860), caused by mutations in UBE2A (MIM *312180), is characterized by craniofacial dysmorphism (synophrys, prominent supraorbital ridges, deep-set, almond-shaped eyes, depressed nasal bridge, prominent columella, hypoplastic alae nasi, and macrostomia), skin anomalies (hirsutism, myxedematous appearance, onychodystrophy), micropenis, moderate to severe intellectual disability (ID), motor delay, impaired/absent speech, and seizures. Hitherto only five familial point mutations and four different deletions including UBE2A have been reported in the literature.

We present eight additional individuals from five families with UBE2A associated ID - three males from a consanguineous family, in whom we identified a small deletion of only 7.1 kb encompassing the first three exons of UBE2A, two related males with a UBE2A missense mutation in exon 4, a patient with a de novo nonsense mutation in exon 6, and two sporadic males with larger deletions including UBE2A. All affected male individuals share the typical clinical phenotype, all carrier females are unaffected and presented with a completely skewed X inactivation in blood. We conclude that 1.) X-linked intellectual disability type Nascimento is a clinically very distinct entity that might be underdiagnosed to date. 2.) So far, all females carrying a familial UBE2A aberration have a completely skewed X inactivation and are clinically unaffected. This should be taken in to account when counselling those families. 3.) The coverage of an array should be checked carefully prior to analysis since not all arrays have a sufficient resolution at specific loci, or alternative quantitative methods should be applied not to miss small deletions.

【 授权许可】

   
2013 Czeschik et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20140725045214258.pdf 1922KB PDF download
37KB Image download
69KB Image download
97KB Image download
【 图 表 】

【 参考文献 】
  • [1]Ropers HH: Genetics of early onset cognitive impairment. Annu Rev Genomics Hum Genet 2010, 11:161-187.
  • [2]Flore LA, Milunsky JM: Updates in the genetic evaluation of the child with global developmental delay or intellectual disability. Semin Pediatr Neurol 2012, 19:173-180.
  • [3]Nascimento RMP, Otto PA, de Brouwer APM, Vianna-Morgante AM: UBE2A, which encodes a ubiquitin-conjugating enzyme, is mutated in a novel X-linked mental retardation syndrome. Am J Hum Genet 2006, 79:549.
  • [4]Budny B, Badura-Stronka M, Materna-Kiryluk A, Tzschach A, Raynaud M, Latos-Bielenska A, Ropers HH: Novel missense mutations in the ubiquitination-related gene UBE2A cause a recognizable X-linked mental retardation syndrome. Clin Genet 2010, 77:541.
  • [5]Haddad DM, Vilain S, Vos M, Esposito G, Matta S, Kalscheuer VM, Craessaerts K, Leyssen M, Nascimento RM, Vianna-Morgante AM, et al.: Mutations in the intellectual disability gene ube2a cause neuronal dysfunction and impair parkin-dependent mitophagy. Mol Cell 2013, 50:831-843.
  • [6]de Leeuw N, Bulk S, Green A, Jaeckle-Santos L, Baker LA, Zinn AR, Kleefstra T, van der Smagt JJ, Vianne Morgante AM, de Vries BBA, et al.: UBE2A deficiency syndrome: Mild to severe intellectual disability accompanied by seizures, absent speech, urogenital, and skin anomalies in male patients. Am J Med Genet A 2010, 152A:3084.
  • [7]Honda S, Orii KO, Kobayashi J, Hayashi S, Imamura A, Imoto I, Nakagawa E, Goto Y-i, Inazawa J: Novel deletion at Xq24 including the UBE2A gene in a patient with X-linked mental retardation. J Hum Genet 2010, 55:244.
  • [8]Koressaar T, Remm M: Enhancements and modifications of primer design program Primer3. Bioinformatics 2007, 23:1289-1291.
  • [9]Untergasser A, Cutcutache I, Koressaar T, Ye J, Faircloth BC, Remm M, Rozen SG: Primer3–new capabilities and interfaces. Nucleic Acids Res 2012, 40:e115.
  • [10]Sharp A, Robinson D, Jacobs P: Age- and tissue-specific variation of X chromosome inactivation ratios in normal women. Hum Genet 2000, 107:343-349.
  • [11]Carrel L, Willard HF: An assay for X inactivation based on differential methylation at the fragile X locus, FMR1. Am J Med Genet 1996, 64:27-30.
  • [12]Firth HV, Richards SM, Bevan AP, Clayton S, Corpas M, Rajan D, Van Vooren S, Moreau Y, Pettett RM, Carter NP: DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources. Am J Hum Genet 2009, 84:524-533.
  • [13]Grasshoff U, Bonin M, Goehring I, Ekici A, Dufke A, Cremer K, Wagner N, Rossier E, Jauch A, Walter M, et al.: De novo MECP2 duplication in two females with random X-inactivation and moderate mental retardation. Eur J Hum Genet 2011, 19:507-512.
  • [14]Bijlsma EK, Collins A, Papa FT, Tejada MI, Wheeler P, Peeters EA, Gijsbers AC, van de Kamp JM, Kriek M, Losekoot M, et al.: Xq28 duplications including MECP2 in five females: Expanding the phenotype to severe mental retardation. Eur J Med Genet 2012, 55:404-413.
  • [15]Bhat KP, Greer SF: Proteolytic and non-proteolytic roles of ubiquitin and the ubiquitin proteasome system in transcriptional regulation. Biochim Biophys Acta 2011, 1809:150.
  • [16]Cabezas DA, Slaugh R, Abidi F, Arena JF, Stevenson RE, Schwartz CE, Lubs HA: A new X linked mental retardation (XLMR) syndrome with short stature, small testes, muscle wasting, and tremor localises to Xq24-q25. J Med Genet 2000, 37:663-668.
  • [17]Tarpey PS, Raymond FL, O'Meara S, Edkins S, Teague J, Butler A, Dicks E, Stevens C, Tofts C, Avis T, Barthorpe S, Buck G, Cole J, Gray K, Halliday K, Harrison R, Hills K, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Varian J, West S, Widaa S, Mallya U, et al.: Mutations in CUL4B, which encodes a ubiquitin E3 ligase subunit, cause an X-linked mental retardation syndrome associated with aggressive outbursts, seizures, relative macrocephaly, central obesity, hypogonadism, pes cavus, and tremor. Am J Hum Genet 2007, 80:345.
  • [18]Gécz J, Turner G, Nelson J, Partington M: The Börjeson-Forssman-Lehman syndrome (BFLS, MIM #301900). Eur J Hum Genet 2006, 14:1233-1237.
  文献评价指标  
  下载次数:31次 浏览次数:10次